Equine Assisted Therapy Research: What the Evidence Shows

Current Research Landscape

The evidence base for equine assisted therapy has grown substantially over the past decade, though it remains relatively modest compared to mainstream psychological interventions. Three systematic reviews have been published since 2017, examining outcomes across diverse populations from autism spectrum conditions to trauma recovery.

Most research consists of pilot studies and small randomised controlled trials, with sample sizes typically ranging from 20 to 50 participants. Larger studies are rare, though a few notable exceptions include a 2019 RCT examining 67 military veterans with PTSD. The heterogeneity of programmes presents a significant challenge—some focus on mounted activities, others purely on ground work, and session structures vary considerably between centres.

Whilst controlled trials are increasing, much of the literature still relies on observational studies and case series. This reflects both the practical challenges of randomisation in therapeutic settings and the relative youth of the field as a research area.

Strongest Evidence Findings

The most robust evidence emerges from trauma-related conditions. A 2018 systematic review identified seven RCTs examining PTSD outcomes, with pooled results suggesting moderate improvements in symptom severity scores. The largest individual study, involving military veterans, found significant reductions in PTSD symptoms at six-month follow-up compared to standard care alone.

For autism spectrum conditions, research indicates particular promise for social communication goals. A 2020 meta-analysis of eight studies found improvements in social functioning measures, though effect sizes were modest and confidence intervals wide. Children participating in structured equine programmes showed greater engagement in social activities and reduced anxiety in novel situations.

Depression and anxiety outcomes show more mixed results. Whilst individual studies often report improvements in mood measures, the evidence lacks the consistency seen in PTSD research. Some trials suggest benefits may be temporary, diminishing within months of programme completion.

Critical Limitations

Sample sizes remain the most significant limitation across the research base. Even systematic reviews struggle with pooling results from studies with fewer than 30 participants each. This makes it difficult to detect true treatment effects and increases the risk that positive findings reflect chance rather than genuine therapeutic benefit.

Blinding presents another substantial challenge. Participants obviously know they're working with horses, and outcome assessors are often aware of group allocation. This introduces potential bias, particularly for self-reported measures like anxiety and depression scales. Few studies have employed truly independent outcome assessment.

Protocol standardisation proves problematic for meta-analysis. Programme duration ranges from single sessions to year-long interventions. Some emphasise riding skills, others focus purely on ground-based activities, and therapeutic frameworks vary from cognitive-behavioural approaches to experiential learning models. This heterogeneity makes it difficult to determine which elements drive any observed benefits.

Publication bias may also skew the evidence base. Negative results are less likely to be published, and the field attracts researchers who may be predisposed to finding positive outcomes.

Evidence Supported vs. Uncertain

The current evidence supports equine assisted therapy as a potentially valuable adjunctive intervention, particularly for trauma-related conditions and autism spectrum disorders. The research suggests it may offer unique benefits for individuals who struggle to engage with traditional therapy settings or who haven't responded to conventional approaches.

However, claims about superiority over established treatments remain unsupported. No high-quality trials have directly compared equine assisted therapy to evidence-based treatments like trauma-focused CBT or exposure therapy. The evidence also cannot yet identify which specific programme elements drive benefits—whether it's the horse interaction, the outdoor setting, or simply increased therapeutic contact time.

Long-term outcomes remain largely unknown. Most studies follow participants for weeks or months, not years. Whether benefits persist and how frequently 'booster' sessions might be needed represents a significant evidence gap.

Mechanisms of action remain speculative. Whilst theories about horses providing immediate feedback and promoting emotional regulation are plausible, these haven't been rigorously tested through controlled studies.

Research Priorities

The field needs larger, multi-centre trials with standardised protocols to establish clearer evidence of effectiveness. Studies comparing equine assisted therapy directly to established treatments would help clarify its place in therapeutic hierarchies.

Mechanism studies using physiological measures—stress hormones, heart rate variability, or neuroimaging—could illuminate how human-horse interactions produce therapeutic effects. This understanding might inform more targeted programme design.

Longer follow-up periods are essential. Current evidence cannot address whether benefits represent temporary mood improvements or lasting therapeutic change. Studies tracking participants for years rather than months would clarify the durability of effects.

Finally, research into optimal programme characteristics remains limited. Questions about session frequency, programme duration, individual versus group formats, and the relative importance of different activities require systematic investigation before evidence-based programme guidelines can be developed.